Literature DB >> 21991203

A case of toxic epidermal necrolysis (ten) with severe chronic ocular complications in a healthy 46-year-old woman.

A Voltan1, B Azzena.   

Abstract

Toxic epidermal necrolysis (TEN), also known as Lyell's syndrome, is a severe drug reaction characterized by extensive destruction of the epidermis and mucosal epithelia. The eyes are typically involved in TEN. The precise pathomechanisms involved remain unknown. We present a case of toxic epidermal necrolysis in a healthy 46-yr-old female patient who had inhaled glycophosphate (herbicide) and was treated with paracetamol, aspirin, and chlorpheniramine. Thirty-five per cent of the skin area was affected by the syndrome, with involvement of conjunctival, gastrointestinal, and respiratory mucous membranes. Topical treatment was performed every day and the patient did not undergo surgery. Complete wound healing was achieved in 47 days. There were acute complications, consisting of infection of the skin areas ( Candida), gastrointestinal bleeding, pleural effusion, and severe ocular mucous membrane damage. The most serious chronic complication was the presence of significant opacity of the corneal epithelium, causing almost complete loss of vision. According to the data in the literature, ocular complications in TEN are frequent and are present in the majority of the patients studied, but are not often severe. Risk factors for the development of ocular complications are not known. Ocular sequelae may appear after the acute period and they can be extremely disabling, even causing almost complete loss of vision. Treatment includes corticosteroids and topical antibiotic therapy in the acute phase and if necessary corneal transplantation in the event of chronic damage to the corneal epithelium.

Entities:  

Keywords:  chronic complication; severe ocular involvement; toxic epidermal necrolysis

Year:  2010        PMID: 21991203      PMCID: PMC3188249     

Source DB:  PubMed          Journal:  Ann Burns Fire Disasters        ISSN: 1592-9558


  36 in total

1.  Long-term ocular complication of Stevens-Johnson syndrome.

Authors:  S S Lehman
Journal:  Clin Pediatr (Phila)       Date:  1999-07       Impact factor: 1.168

Review 2.  Treatment of toxic epidermal necrolysis with moisture-retentive ointment: a case report and review of the literature.

Authors:  Bishara S Atiyeh; Ruwayda Dham; M Fayez Yassin; Kusai A El-Musa
Journal:  Dermatol Surg       Date:  2003-02       Impact factor: 3.398

3.  Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.

Authors:  Yi-Sheng Chang; Fu-Chin Huang; Sung-Huei Tseng; Chao-Kai Hsu; Chung-Liang Ho; Hamm-Ming Sheu
Journal:  Cornea       Date:  2007-02       Impact factor: 2.651

4.  Treatment of extensive toxic epidermal necrolysis in children.

Authors:  M Spies; A P Sanford; J F Aili Low; S E Wolf; D N Herndon
Journal:  Pediatrics       Date:  2001-11       Impact factor: 7.124

5.  Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis.

Authors:  Philippe Paquet; Eric Jacob; Pierre Damas; Jean Pirson; Gérald Piérard
Journal:  Arch Dermatol Res       Date:  2005-10-25       Impact factor: 3.017

6.  Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis.

Authors:  P Paquet; F Paquet; W Al Saleh; P Reper; A Vanderkelen; G E Piérard
Journal:  Am J Dermatopathol       Date:  2000-10       Impact factor: 1.533

Review 7.  Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.

Authors:  Pierre-Dominique Ghislain; Jean-Claude Roujeau
Journal:  Dermatol Online J       Date:  2002-06

8.  Penetrating keratoplasty in cicatrizing conjunctival diseases.

Authors:  I Tugal-Tutkun; Y A Akova; C S Foster
Journal:  Ophthalmology       Date:  1995-04       Impact factor: 12.079

Review 9.  Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Andrea T Borchers; Jennifer L Lee; Stanley M Naguwa; Gurtej S Cheema; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2008-07-09       Impact factor: 9.754

10.  Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

Authors:  I Viard; P Wehrli; R Bullani; P Schneider; N Holler; D Salomon; T Hunziker; J H Saurat; J Tschopp; L E French
Journal:  Science       Date:  1998-10-16       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.